2011
DOI: 10.1016/j.jss.2009.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Safety of Hepatic Resection in Metastatic Disease to the Liver After Yttrium-90 Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
36
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 49 publications
(38 citation statements)
references
References 14 publications
2
36
0
Order By: Relevance
“…In a study by Whitney et al , the investigators have briefly described the histology in four patients with metastatic disease to the liver from different primary sites who underwent hepatic resection 15. Their emphasis was predominantly on the percentage of tumour necrosis, which ranged from 45% to 80%, but the authors did also note moderate to severe hepatic inflammation and fibrosis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In a study by Whitney et al , the investigators have briefly described the histology in four patients with metastatic disease to the liver from different primary sites who underwent hepatic resection 15. Their emphasis was predominantly on the percentage of tumour necrosis, which ranged from 45% to 80%, but the authors did also note moderate to severe hepatic inflammation and fibrosis.…”
Section: Discussionmentioning
confidence: 99%
“…15 Their emphasis was predominantly on the percentage of tumour necrosis, which ranged from 45% to 80%, but the authors did also note moderate to severe hepatic inflammation and fibrosis. Specific details describing the 'hepatic inflammation' referred to were not included in the paper.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Because of the degree of vascularity of these lesions, response rates have been as high as 70%-90%. Several published reports have demonstrated that TACE can reduce hormonal levels, palliate symptoms, and reduce tumor burden in many patients with hepatic carcinoid metastases [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…At present only single case reports or small uncontrolled series describe neo-adjuvant strategies with radio-receptor (90)Y-DOTATOC therapy,63 resin (90)Y-microspheres radio-embolisation64 or chemotherapy for downsizing hepatic metastasis of NEC before liver surgery. Neo-adjuvant strategies are not yet established in liver surgery of NEC.…”
Section: Surgery Of Liver Metastasesmentioning
confidence: 99%